Clinical Controversies in Multiple Myeloma

Cleveland Clinic Foundation and the Multiple Myeloma Research Foundation
Last Modified: July 15, 2006

Conference Dates: Friday, September 8, 2006: 8:00AM - 11:00AM
Conference Location: Intercontinental Hotel, 9801 Carengie Avenue, Cleveland, Ohio

Sponsoring Group: Cleveland Clinic Foundation and the Multiple Myeloma Research Foundation

Conference Web Page URL:

Topics Covered:

  • Staging/Prognostic Indicators
  • Frontline Therapy
  • The Role of Stem Cell Transplantation
  • Supportive Care and Bone Disease
  • Novel Therapies and Clinical Trials

Conference Objectives:

  1. Identify the prognostic indicators and diagnostic approaches to multiple myeloma;
  2. Discuss the latest advances in stem cell transplantation, treatment for bone disease, and supportive care management;
  3. Describe the role and appropriate use of novel treatments for multiple myeloma throughout the disease progression.

Who Should Attend: Hematologiests, Medical Oncologists, Oncology Nurses, Internists with recently diagnosed patients

Registration Information: Advanced registration is requested. Registration deadline is Tuesday, September 5, 2006. Register online at: For more information visit:

Conference Fees: Free

Continuing Education: Yes


My Cancer Experience
by Bob Riter
October 06, 2015

Related News

Recommendations Presented for MRI Use in Multiple Myeloma

Feb 3, 2015

MRI is gold standard for imaging axial skeleton, assessing painful lesions, ID'ing benign fractures

Continuous Therapy Improves Survival in Multiple Myeloma

Aug 31, 2015

Benefit seen in progression-free, overall survival compared with fixed duration of therapy

Revised Staging System Prognostic for Multiple Myeloma

Aug 4, 2015

ISS plus chromosomal abnormalities, lactate dehydrogenase prognostic in multiple myeloma